HemeBot Hosts HemeNext Conference: Yashpal Singh Rawat on Fortis Leading India’s Innovation Journey
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn:
”The Institute of Blood Disorders at Fortis Hospital, Gurugram successfully organised the HemeNext conference, a landmark event that brought together renowned faculty and expert panelists from across the globe.
During the session, Dr Rahul Bhargava and Dr Vikas Dua showcased a visionary leap for the future of Hematology and pediatric hemato-oncology, Genomics, AI and infectious diseases highlighting how robotics and intelligent automation are poised to transform diagnosis, precision, and patient care in the years ahead.
Hemebot, a humanoid hosted the event, welcoming dignitaries, and delivered video podcasts with our clinicians.
Fortis continues to pioneer innovation in healthcare and the lead the way for India
The event was powerfully led by Dr. Rahul Bhargava, Dr. Vikas Dua and Dr. Shrinidhi, showcasing Fortis Gurugram’s leadership in advanced hematology.”
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk